What is the registration number for DO DAVA ONCOLOGY, LP ... FACILITATING SUCCESSFUL DRUG DEVELOPMENT?

DO DAVA ONCOLOGY, LP ... FACILITATING SUCCESSFUL DRUG DEVELOPMENT is registered under USPTO registration number 4185771.

DOD

USPTO Trademark Record

ABANDONED

DO DAVA ONCOLOGY, LP ... FACILITATING SUCCESSFUL DRUG DEVELOPMENT

Q: Who owns the DO DAVA ONCOLOGY, LP ... FACILITATING SUCCESSFUL DRUG DEVELOPMENT trademark?

The DO DAVA ONCOLOGY, LP ... FACILITATING SUCCESSFUL DRUG DEVELOPMENT trademark is owned by Dava Oncology, L.P..

Q: What class is the DO DAVA ONCOLOGY, LP ... FACILITATING SUCCESSFUL DRUG DEVELOPMENT trademark registered in?

The DO DAVA ONCOLOGY, LP ... FACILITATING SUCCESSFUL DRUG DEVELOPMENT trademark is registered in Class 042 (Scientific, technology & SaaS services).

Q: What is the serial number for DO DAVA ONCOLOGY, LP ... FACILITATING SUCCESSFUL DRUG DEVELOPMENT?

The USPTO serial number for DO DAVA ONCOLOGY, LP ... FACILITATING SUCCESSFUL DRUG DEVELOPMENT is 85490172.

SN 85490172·Reg 4185771·Filed Dec 08, 2011

Owner Dava Oncology, L.P.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

DO DAVA ONCOLOGY, LP ... FACILITATING SUCCESSFUL DRUG DEVELOPMENT (Serial No. 85490172), Registration No. 4185771, is a abandoned US trademark filed on Dec 08, 2011 by Dava Oncology, L.P.. This trademark covers Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

DO DAVA ONCOLOGY, LP ... FACILITATING SUCCESSFUL DRUG DEVELOPMENT (Reg. #4185771) is an abandoned US trademark that was filed in 2011 but has since been abandoned. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 08, 2011

SERIAL

85490172

REG#

4185771

REGISTERED

Aug 07, 2012

Owner

Applicant

Dava Oncology, L.P.

Entity

Limited Partnership

State

Address

4 Forest Plaza, 12222 Merit Dr., #820, Dallas, TX, 75251

Country

Attorney

Law firm

DAVA Oncology, LP

Address

5420 LBJ Freeway, Suite 410, Dallas, TX 75240, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateDec 08, 2011

Serial Number85490172

Registration No.4185771

Registration DateAug 07, 2012

Status DateMar 08, 2019

Published for OppositionMay 22, 2012

Mark TypeStylized characters

Status DescriptionDead and cancelled, Section 8

Filing Signals

FILED

2011

YEARS AGO

15y

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Jul 01, 2011

First use in commerce: Jul 01, 2011

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

21 events

CANCELLED SEC. 8 (6-YR)

Mar 08, 2019

CANCELLED SEC. 8 (6-YR)

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Aug 07, 2017

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

May 21, 2014

TEAS CHANGE OF CORRESPONDENCE RECEIVED

May 21, 2014

TEAS CHANGE OF CORRESPONDENCE RECEIVED

REGISTERED-PRINCIPAL REGISTER

Aug 07, 2012

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

May 22, 2012

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 22, 2012

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 02, 2012

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ASSIGNED TO LIE

Apr 16, 2012

ASSIGNED TO LIE

LAW OFFICE PUBLICATION REVIEW COMPLETED

Apr 16, 2012

LAW OFFICE PUBLICATION REVIEW COMPLETED

NON-FINAL ACTION WRITTEN

Mar 26, 2012

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Mar 26, 2012

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 26, 2012

NOTIFICATION OF NON-FINAL ACTION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Mar 26, 2012

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Mar 26, 2012

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Mar 26, 2012

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Mar 26, 2012

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 26, 2012

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Mar 20, 2012

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 14, 2011

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Dec 12, 2011

NEW APPLICATION ENTERED

DO DAVA ONCOLOGY, LP ... FACILITATING SUCCESSFUL DRUG DEVELOPMENT

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Dava Oncology, L.P.

Other Marks in Class 042 — Scientific, technology & SaaS services

Resources

Company